Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 21387396)

1.

ROCK1 as a potential therapeutic target in osteosarcoma.

Liu X, Choy E, Hornicek FJ, Yang S, Yang C, Harmon D, Mankin H, Duan Z.

J Orthop Res. 2011 Aug;29(8):1259-66. doi: 10.1002/jor.21403. Epub 2011 Mar 8.

PMID:
21387396
2.

Cyclin G-associated kinase is necessary for osteosarcoma cell proliferation and receptor trafficking.

Susa M, Choy E, Liu X, Schwab J, Hornicek FJ, Mankin H, Duan Z.

Mol Cancer Ther. 2010 Dec;9(12):3342-50. doi: 10.1158/1535-7163.MCT-10-0637. Epub 2010 Sep 29.

3.

Combined microRNA-340 and ROCK1 mRNA profiling predicts tumor progression and prognosis in pediatric osteosarcoma.

Cai H, Lin L, Cai H, Tang M, Wang Z.

Int J Mol Sci. 2014 Jan 6;15(1):560-73. doi: 10.3390/ijms15010560.

4.

The kinase Mirk is a potential therapeutic target in osteosarcoma.

Yang C, Ji D, Weinstein EJ, Choy E, Hornicek FJ, Wood KB, Liu X, Mankin H, Duan Z.

Carcinogenesis. 2010 Apr;31(4):552-8. doi: 10.1093/carcin/bgp330. Epub 2009 Dec 30.

5.

Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis.

Ryu K, Choy E, Yang C, Susa M, Hornicek FJ, Mankin H, Duan Z.

J Orthop Res. 2010 Jul;28(7):971-8. doi: 10.1002/jor.21088.

PMID:
20063378
6.

Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferation.

Duan Z, Zhang J, Choy E, Harmon D, Liu X, Nielsen P, Mankin H, Gray NS, Hornicek FJ.

Clin Cancer Res. 2012 Sep 1;18(17):4580-8. doi: 10.1158/1078-0432.CCR-12-1157. Epub 2012 Jul 12.

7.

Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma.

Duan Z, Ji D, Weinstein EJ, Liu X, Susa M, Choy E, Yang C, Mankin H, Hornicek FJ.

Cancer Lett. 2010 Jul 28;293(2):220-9. doi: 10.1016/j.canlet.2010.01.014. Epub 2010 Feb 9.

PMID:
20144850
8.

Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma.

Wang YC, Zheng LH, Ma BA, Zhou Y, Zhang MH, Zhang DZ, Fan QY.

Acta Histochem. 2011 Jul;113(4):402-8. doi: 10.1016/j.acthis.2010.03.002. Epub 2010 May 23.

PMID:
20546860
9.

Functional and biological analysis of Bcl-xL expression in human osteosarcoma.

Wang ZX, Yang JS, Pan X, Wang JR, Li J, Yin YM, De W.

Bone. 2010 Aug;47(2):445-54. doi: 10.1016/j.bone.2010.05.027. Epub 2010 May 23.

PMID:
20580954
10.

CDH11 expression is associated with survival in patients with osteosarcoma.

Nakajima G, Patino-Garcia A, Bruheim S, Xi Y, San Julian M, Lecanda F, Sierrasesumaga L, Müller C, Fodstad O, Ju J.

Cancer Genomics Proteomics. 2008 Jan-Feb;5(1):37-42.

11.

microRNA-145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1.

Lei P, Xie J, Wang L, Yang X, Dai Z, Hu Y.

Mol Med Rep. 2014 Jul;10(1):155-60. doi: 10.3892/mmr.2014.2195. Epub 2014 Apr 28.

PMID:
24789502
13.

[The effect of resistance-related proteins on the prognosis and survival of patients with osteosarcoma: an immunohistochemical analysis].

Ozger H, Eralp L, Atalar AC, Toker B, Esberk Ateş L, Sungur M, Bilgiç B, Ayan I.

Acta Orthop Traumatol Turc. 2009 Jan-Feb;43(1):28-34. doi: 10.3944/AOTT.2009.028. Turkish.

PMID:
19293613
14.

Targeting hedgehog-GLI-2 pathway in osteosarcoma.

Yang W, Liu X, Choy E, Mankin H, Hornicek FJ, Duan Z.

J Orthop Res. 2013 Mar;31(3):502-9. doi: 10.1002/jor.22230. Epub 2012 Sep 11.

PMID:
22968906
15.

Oncogenic roles of astrocyte elevated gene-1 (AEG-1) in osteosarcoma progression and prognosis.

Wang F, Ke ZF, Sun SJ, Chen WF, Yang SC, Li SH, Mao XP, Wang LT.

Cancer Biol Ther. 2011 Sep 15;12(6):539-48. doi: 10.4161/cbt.12.6.16301. Epub 2011 Sep 15.

16.

Expression and prognostic relevance of PRAME in primary osteosarcoma.

Tan P, Zou C, Yong B, Han J, Zhang L, Su Q, Yin J, Wang J, Huang G, Peng T, Shen J.

Biochem Biophys Res Commun. 2012 Mar 23;419(4):801-8. doi: 10.1016/j.bbrc.2012.02.110. Epub 2012 Feb 27.

PMID:
22390931
17.

MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1.

Zhou X, Wei M, Wang W.

Biochem Biophys Res Commun. 2013 Aug 9;437(4):653-8. doi: 10.1016/j.bbrc.2013.07.033. Epub 2013 Jul 18.

PMID:
23872151
18.

The β5/focal adhesion kinase/glycogen synthase kinase 3β integrin pathway in high-grade osteosarcoma: a protein expression profile predictive of response to neoadjuvant chemotherapy.

Le Guellec S, Moyal EC, Filleron T, Delisle MB, Chevreau C, Rubie H, Castex MP, de Gauzy JS, Bonnevialle P, Gomez-Brouchet A.

Hum Pathol. 2013 Oct;44(10):2149-58. doi: 10.1016/j.humpath.2013.03.020. Epub 2013 Jul 8.

PMID:
23845472
19.

Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells.

Ma X, Yang Y, Wang Y, An G, Lv G.

Cancer Lett. 2010 Dec 28;299(2):171-81. doi: 10.1016/j.canlet.2010.08.016. Epub 2010 Sep 19.

PMID:
20855150
20.

Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.

Baumhoer D, Smida J, Specht K, Bink K, Quintanilla-Martinez L, Rosemann M, Siggelkow H, Nathrath WB, Atkinson MJ, Bielack S, Jundt G, Nathrath M.

Hum Pathol. 2011 Jun;42(6):859-66. doi: 10.1016/j.humpath.2010.09.016. Epub 2011 Feb 2.

PMID:
21292304
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk